Alterations in theophylline metabolism during the first year of life

• Published in: Clinical pharmacology and therapeutics Vol. 54; no. 4; p. 351
• Main Authors: Kraus, D M, Fischer, J H, Reitz, S J, Kecskes, S A, Yeh, T F, McCulloch, K M, Tung, E C, Cwik, M J
• Format: Journal Article
• Language: English
• Published: United States 01-10-1993
• Subjects: Aging - blood; Aging - metabolism; Aging - urine; Analysis of Variance; Caffeine - blood; Humans; Infant; Infant, Newborn; Linear Models; Metabolic Clearance Rate; Theophylline - pharmacokinetics
• ISSN: 0009-9236
• DOI: 10.1038/clpt.1993.160

Maturational changes in theophylline disposition were evaluated in 52 infants (gestational age, 24 to 40 weeks; postnatal age, 2 to 69 weeks) receiving maintenance theophylline therapy. Theophylline and metabolites were measured in serum and urine at steady state, and the influence of clinical parameters on the maturational changes was analyzed by multiple stepwise linear regression. Theophylline clearance and urine metabolite pattern reached adult values at 55 weeks' postconceptional age. Serum caffeine concentrations greater than 1 microgram/ml occurred in infants up to 50 weeks' postconceptional age. Disappearance of serum caffeine concentrations and maturation of theophylline clearance were primarily related (p < 0.001) to development of the demethylation pathway to 3-methylxanthine. Postconceptional age was the major factor (p < 0.001) explaining the interpatient variability in theophylline clearance (r2 = 0.57), serum caffeine to theophylline ratio (r2 = 0.46), and urinary excretion of theophylline (r2 = 0.51), caffeine (r2 = 0.49), 1,3-methyluric acid (r2 = 0.32), 1-methyluric acid (r2 = 0.53), and 3-methylxanthine (r2 = 0.58). Our findings indicate that postconceptional age rather than postnatal age should be used as a maturational marker during theophylline therapy in infancy.